Embry Holdings Reports HK$58 Million Loss Attributable to Owners for H1 2025 Despite HK$604.5 Million Revenue; E-commerce Sales Up 7.6% Year-on-Year

Reuters
08/29
Embry Holdings Reports HK$58 Million Loss Attributable to Owners for H1 2025 Despite HK$604.5 Million Revenue; E-commerce Sales Up 7.6% Year-on-Year

Embry Holdings Limited has announced its unaudited condensed consolidated results for the six months ended 30 June 2025. The company's revenue stood at approximately HK$604.5 million, a decrease from HK$631.4 million reported for the corresponding period in 2024. Gross profit for the period was approximately HK$442.3 million, down from HK$478.3 million in the prior period. The company recorded a loss attributable to owners of approximately HK$58.0 million, influenced by non-recurring, unrealised, and non-cash items totaling approximately HK$22.1 million. E-commerce sales saw an increase of 7.6% year-on-year, reaching HK$236.8 million. The Chinese Mainland market remains the main source of income, contributing HK$582.5 million, representing 96.4% of the Group's total revenue. The flagship brand, EMBRY FORM, contributed 64.7% of the total revenue, amounting to HK$391.1 million, up by 1.5% from the prior period. The company intensified promotional activities in the second quarter, leading to an improvement in offline retail performance with a reduced rate of decline compared to the first quarter.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Embry Holdings Limited published the original content used to generate this news brief on August 29, 2025, and is solely responsible for the information contained therein.

免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。

热议股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10